THE ABCEASE™ KIT
Taking the Fuss out of Pus
The Abcease™ Kit is a sterile, single-use device developed to enable safe, effective skin abscess drainage outside of the operating theatre. Designed for use in ambulatory settings, it integrates skin entry, drainage, and fluid collection into one streamlined system.
The Abcease™ Kit is designed to reduce reliance on hospital theatres and general anaesthesia, while also providing safe, controlled access to deep skin abscesses with minimal risk to surrounding structures. This shift improves patient comfort and recovery while easing pressure on public healthcare resources.
As skin abscess rates rise globally, and hospitals face growing demand, resource shortages, and escalating costs, Abcease™ offers a cost-effective, patient-centred solution to a long-standing clinical problem.
Key features
1. Sterile, single-use system with an integrated pathology collection vessel
The Abcease™ Kit will integrate entry, drainage, pathology collection and exudate collection components to streamline treatment and aftercare.
2. Suitable for superficial and deep skin abscesses
The Abcease™ Kit components will leverage a controlled turning motion to move safely through tissue to reach the abscess whilst minimising the need for in-theatre treatment with general anaesthesia.
3. Increased accessibility: shifting treatment to outpatient settings
The Abcease™ Kit will shift treatment from a high-cost environment (theatre) with associated 2-3 day inpatient stay and general anaesthesia to a lower-cost environment with ambulatory care and local anaesthesia
The Abcease™ Kit is currently in pre-clinical development. It is not yet commercially available.
Innovative Concept
Whilst many devices are invented, and then search for an application, this novel medical device was created specifically to address a known clinical need. Inova Medical employed the ‘Biodesign’ design thinking approach that has generate success at Stanford for many years. Since inception, the inova team have engaged with the Western Australian biodesign, medtech and innovation communities, and our networks span major universities, hospitals, and government research organisations. The Inova Medical team have worked with The University of Western Australia’s Master of Biotechnology programme to refine aspects of the business plan, have conducted proof of concept testing at the Clinical Training and Evaluation Centre (CTEC), and were accepted into the national CSIRO accelerator course to develop their understanding of their customer needs utilising the Lean Canvas model. The device is protected by a patents, and strategic world-wide protection will be pursued. Each stage of the project has been undertaken to further ‘de-risk’ the project, and prepare for investment, regulatory approval, and commercialisation.